Passionate and ambitious aspiring scientist specializing in drug discovery. Eager to contribute innovative solutions to the field of pharmaceutical research. Proficient in computer-aided drug design, molecular docking, and research article writing. Committed to pushing the boundaries of scientific knowledge and making a meaningful impact in the world of drug development.Certifications:Certificate in Drug DiscoveryUniversity of California, San Diego Projects:Molecular Docking of DemethoxycurcuminConducted an in-depth study on the molecular docking of demethoxycurcumin, a bioactive compound, to target multiple receptors associated with various diseases, including cancer, Alzheimer's disease, COVID-19, and inflammatory conditions. Analyzed binding affinities and interactions, providing valuable insights for potential drug development.Cancer Receptor Targeting: Investigated the binding affinity and interactions of demethoxycurcumin with key receptors implicated in various types of cancer, paving the way for potential anticancer drug development.Alzheimer's Disease: Explored the molecular interactions between demethoxycurcumin and relevant targets in Alzheimer's disease, contributing to the development of therapeutics for this neurodegenerative disorder.COVID-19: Examined the potential of demethoxycurcumin as an antiviral agent by studying its interactions with COVID-19-related protein targets.Anti-inflammatory Properties: Investigated the binding modes of demethoxycurcumin with receptors involved in inflammatory pathways, offering insights into its anti-inflammatory potential.Skills:Computer-Aided Drug Design (CADD)Molecular DockingDrug Target IdentificationPharmacophore ModelingStructure-Based Drug DesignLigand-Based Drug DesignResearch Article WritingData Analysis